HeadaTerm 2: The Most Affordable FDA Cleared Innovative OTC Anti-Migraine Device
- Written by PR Newswire
VANCOUVER, BC, April 2, 2024 /PRNewswire/ -- WAT Medical Enterprise achieves a major milestone: HeadaTerm 2 receives the OTC clearance from the U.S. Food and Drug Administration (FDA), making it one of the only wearable anti-migraine devices that is available without a prescription in the U.S.
Using neuromodulation technology, HeadaTerm 2...
Read more: HeadaTerm 2: The Most Affordable FDA Cleared Innovative OTC Anti-Migraine Device














